• 1
    IDF. Diabetes Atlas, 5th edition. Unwin N, Whiting D, Guariguata L, Ghyoot G, Gan D, eds. Brussels, Belgium: International Diabetes Federation, 2011.
  • 2
    Ramachandran A, Ma RC, Snehalatha C. Diabetes in Asia. Lancet2010; 375: 408418.
  • 3
    Chan JCN, Malik V, Jia W, Kadowaki T, Yajnik CS, Yoon KH et al.Diabetes in Asia: epidemiology, risk factors, and pathophysiology. J Am Med Assoc2009; 301: 21292140.
  • 4
    Lee JW, Brancati FL, Yeh HC. Trends in the prevalence of type 2 diabetes in Asians versus Whites. Diabetes Care2011; 34: 353357.
  • 5
    Patel KC, Bhopal R. Diabetes epidemic in the South Asian Diaspora: action before desperation. J Roy Soc Med2007; 100: 115116.
  • 6
    Dong Y, Gao W, Nan H, Yu H, Li F, Duan W et al.Prevalence of Type 2 diabetes in urban and rural Chinese populations in Qingdao, China. Diabet Med2005; 22: 14271433.
  • 7
    Hu FB. Globalization of diabetes: the role of diet, lifestyle, and genes. Diabetes Care2011; 34: 12491257.
  • 8
    Pollin TI. Epigenetics and diabetes risk: not just for imprinting anymore?Diabetes2011; 60: 18591860.
  • 9
    Mckeigue PM, Pierpoint T, Ferrie JE, Marmot MG. Relationship of glucose intolerance and hyperinsulinemia to body-fat pattern in South Asians and Europeans. Diabetologia1992; 35: 785791.
  • 10
    Abate N, Chandalia M, Snell PG, Grundy SM. Adipose tissue metabolites and insulin resistance in non-diabetic Asian Indian men. J Clin Endocrinol Metab2004; 89: 27502755.
  • 11
    Snehalatha C, Ramachandran A, Satyavani K, Vallabi MY, Vijay V. Computed axial tomographic scan measurement of abdominal fat distribution and its correlation with anthropometry and insulin secretion in healthy Asian Indians. Metabolism1997; 46: 12201224.
  • 12
    Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, Grundy SM et al.Insulin resistance and body fat distribution in South Asian men compared to Caucasian men. PloS ONE2007; 2: 812.
  • 13
    Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al.Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care1997; 20: 537544.
  • 14
    Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al.The Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med2002; 346: 393403.
  • 15
    Lindstrom J, Ilanne-Parikka P, Peltonen M, Aunola S, Eriksson JG, Hemio K et al.The Finnish Diabetes Prevention Study Group: sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet2006; 368: 16731679.
  • 16
    Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V. Indian Diabetes Prevention Programme (IDPP). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia2006; 49: 289297.
  • 17
    Ramachandran A, Snehalatha C, Mary S, Selvam S, Kumar CK, Seeli AC et al.Pioglitazone does not enhance effectiveness of lifestyle modification in preventing conversion of impaired glucose tolerance to diabetes in Asian Indians: results of the Indian Diabetes Prevention Programme-2 (IDPP-2). Diabetologia2009; 52: 10191026.
  • 18
    Snehalatha C, Mary S, Selvam S, Sathish Kumar CK, Shetty SB, Nanditha A et al.Changes in insulin secretion and insulin sensitivity in relation to the glycaemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1). Diabetes Care2009; 32: 796801.
  • 19
    The Diabetes Prevention Program Research Group. Role of insulin secretion and sensitivity in the evolution of type 2 diabetes in the diabetes prevention program: effects of lifestyle intervention and metformin. Diabetes2005; 54: 24042414.
  • 20
    Uusuitupa M, Lindi V, Louheranta A, Salopuro T, Lindstrom J, Tuomilehto J. Finnish Diabetes Prevention Study Group. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results form the Finnish Diabetes Prevention Study. Diabetes2003; 52: 25322538.
  • 21
    Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med.2008; 359: 15771589.
  • 22
    Kosaka K, Noda M, Kuzuya T. Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males. Diabetes Res Clin Pract2005; 67: 152162.
  • 23
    Ramachadran A, Snehalatha C. Diabetes prevention programs. Med Clin N Am2011; 95: 353372.
  • 24
    Wijesuriya M, Williams R, Yajnik C. The Kathmandu Declaration: ‘Life Circle’ approach to prevention and care of diabetes mellitus. Diabetes Res Clin Pract.2010; 87: 2026.
  • 25
    Yajnik CS, Deshmukh US. Maternal nutrition, intrauterine programming and consequential risks in the offspring. Rev Endocr Metab Disord2008; 9: 203211.
  • 26
    Ramachandran A, Snehalatha C, Yamuna A, Murugesan N, Narayan KM. Insulin resistance and clustering of cardiometabolic risk factors in urban teenagers in southern India. Diabetes Care2007; 30: 18281833.
  • 27
    Misra A, Khurana L, Vikram NK, Goel A, Wasir JS. Metabolic syndrome in children: current issues and South Asian perspective. Nutrition2007; 23: 895910.
  • 28
    Bavdekar A, Yajnik CS, Fall CH, Bapat S, Pandit AN, Deshpande V et al.Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?Diabetes1999; 48: 24222429.
  • 29
    Khunti K, Stone MA, Bankart J, Sinfield P, Pancholi A, Walker S et al.Primary prevention of type 2 diabetes and heart disease: action research in secondary schools serving an ethnically diverse UK population. J Public Health2007; 30: 3037.
  • 30
    Gill T. Young people with diabetes and obesity in Asia: a growing epidemic. Diabetes Voice2007; 52: 2022.
  • 31
    Spijkerman AM, Yuyun MF, Griffin SJ, Dekker JM, Nijpels G, Wareham NJ. The performance of a risk score as a screening test for undiagnosed hyperglycaemia in ethnic minority groups: data from the 1999 Health Survey for England. Diabetes Care2004; 27: 116122.
  • 32
    Gray LJ, Tringham JR, Davies MJ, Webb DR, Jarvis J, Skinner TC et al.Screening for type 2 diabetes in multiethnic setting using known risk factors to identify those at high risk: a cross-sectional study. Vasc Health Risk Manag2010; 6: 837842.
  • 33
    Murugesan N, Snehalatha C, Shobhana R, Roglic G, Ramachandran A. Awareness about diabetes and its complications in the general and diabetic population in a city in southern India. Diabetes Res Clin Pract2007; 77: 433437.
  • 34
    Chowdhury TA, Hitman GA. Type 2 diabetes in people of South Asian Origin: potential strategies for prevention. Br J Diabetes Vasc Disease2007; 7: 279282.
  • 35
    Sohal PS. Prevention and management of diabetes in South Asians. Can J Diabetes2008; 32: 206210.
  • 36
    Goenka S, Prabhakaran D, Ajay VS, Reddy KS. Preventing cardiovascular disease in India: translating evidence to action. Curr Sci2009; 97: 367377.
  • 37
    Siegel K, Narayan KMV, Kinra S. Finding A policy solution to India’s diabetes epidemic. Health Aff2008; 4: 10771090.
  • 38
    Diabetes Prevention Intervention Study. A Randomized Clinical Trial to Prevent Type 2 Diabetes in Persons with Impaired Glucose Tolerance (IGT).Available at Last accessed 26 April 2012.
  • 39
    National Programme for Prevention and Control of Diabetes, Cardiovascular Diseases and Stroke (NPDCS). A New Initiative for a Healthy Nation.Available at Last accessed 11 March 2008.
  • 40
    Nishtar S. The National Action Plan for Prevention and Control of Non-Communicable Diseases and Health Promotion in Pakistan. Islamabad: Ministry of Health, Government of Pakistan, 2005.4350
  • 41
    Wijesuriya M, Gulliford M, Charlton J, Vasantharaja L, Viberti G, Gnudi L et al.High prevalence of cardio-metabolic risk factors in a young urban Sri-Lankan population. PLoS One2012; 7: e31309.
  • 42
    Bhattarai MD, Singh DL. Learning the lessons—preventing type 2 diabetes in Nepal. Diabetes Voice2007; 52: 911.
  • 43
    Shah B, Menon G. Burden of Non-Communicable Disease in India. New Delhi: Indian Council of Medical Research, 2005.
  • 44
    Weber MB, Ranjani H, Meyers GC, Mohan V, Narayan KMV. A model of translational research for diabetes prevention in low- and middle-income countries: The Diabetes Community Lifestyle Improvement Program (D-CLIP) trial. Prim Care Diabetes2012; 6: 39.
  • 45
    National Institutes of Health. A Culturally Tailored Lifestyle Intervention to Prevent Diabetes in South Asians (SHAPE). Available at Last accessed 18 April 2012.
  • 46
    World Diabetes Foundation. Newsletter Q2_07_Primary Prevention in Indian Schools. Available at Last accessed 18 April 2012.
  • 47
    Diabetes UK and SAHF. Recommendations on Diabetes Research Priorities for British South Asians. Currently or Recently Funded Diabetes Research involving British South Asian Subjects. Available at Last accessed 17 April 2012.
  • 48
    National Diabetes Education Program. Website. Available at Last accessed 24 January 2012.
  • 49
    Grace C, Begum R, Subhani S, Kopelman P, Greenhalgh T. Prevention of type 2 diabetes in British Bangladeshis: qualitative study of community, religious, and professional perspectives. Br Med J2008; 337: A1931.
  • 50
    European Commission. Fighting diabetes and obesity – the EPI-MIGRANT, MEDIGENE, RODAM and GIFTS research projects. Available at Last accessed 26 April 2012.